Discover
VRCA
Verrica Pharmaceuticals Inc.
5.44
1 x 5.50
1 x 6.93
bid
ask
-
0.05
0.91%
5 @ 04:00 PM
5.39 -0.05 (0.92%)
| Ytd | -34.54% | |
| 1y | -29.26% |
5.40
day range
5.64
3.28
52 week range
9.82
| Open | 5.50 | Prev Close | 5.49 | Low | 5.40 | High | 5.64 | Mkt Cap | 57.95M |
| Vol | 11.78K | Avg Vol | 56.38K | EPS | -0.82 | P/E | -6.63 | Forward P/E | -1.19 |
| Beta | 1.47 | Short Ratio | 3.19 | Inst. Own | 15.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 6.10 | 200-d Avg | 6.05 | 1yr Est | 6.33 |
| Income Statement | |||
| Total Revenue | 5.02M | ||
| Revenues (USD) | 5.02M | ||
| Cost of Revenue | 889.00K | ||
| Gross Profit | 4.13M | ||
| Operating Expenses | 13.85M | ||
| Research and Development Expense | 3.86M | ||
| Selling, General and Administrative Expense | 9.99M | ||
| Operating Income | -9.71M | ||
| Interest Expense | 160.00K | ||
| Net Income | -9.68M | ||
| Net Income Common Stock | -9.68M | ||
| Net Income Common Stock (USD) | -9.68M | ||
| Consolidated Income | -9.68M | ||
| Earnings per Basic Share | -0.45 | ||
| Earnings per Basic Share (USD) | -0.45 | ||
| Earnings per Diluted Share | -0.45 | ||
| Earning Before Interest & Taxes (EBIT) | -9.52M | ||
| Earning Before Interest & Taxes (USD) | -9.52M | ||
| Weighted Average Shares | 21.31M | ||
| Weighted Average Shares Diluted | 21.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.60M | ||
| Cash and Equivalents (USD) | 20.60M | ||
| Trade and Non-Trade Receivables | 7.81M | ||
| Current Assets | 34.13M | ||
| Property, Plant & Equipment Net | 1.66M | ||
| Total Assets | 38.79M | ||
| Debt Current | 744.00K | ||
| Total Debt | 1.44M | ||
| Current Liabilities | 16.22M | ||
| Debt Non-Current | 698.00K | ||
| Total Liabilities | 22.73M | ||
| Accumulated Retained Earnings (Deficit) | -334.59M | ||
| Shareholders Equity | 16.06M | ||
| Shareholders Equity (USD) | 16.06M | ||
| Assets Non-Current | 4.66M | ||
| Total Debt (USD) | 1.44M | ||
| Deferred Revenue | 1.03M | ||
| Inventory | 1.97M | ||
| Liabilities Non-Current | 6.51M | ||
| Trade and Non-Trade Payables | 2.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 194.00K | ||
| Net Cash Flow from Financing | -120.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.28M | ||
| Issuance (Purchase) of Equity Shares | -9.00K | ||
| Issuance (Repayment) of Debt Securities | -111.00K | ||
| Net Cash Flow from Operations | -9.16M | ||
| Share Based Compensation | 897.00K | ||